RPG Life Sciences
RPGLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Harsh Goenka · MD: Yugal Sikri · Listing date: June 11, 2008 · Employees: 1107 · Mumbai · http://www.rpglifesciences.com

Stock Price vs Company Growth
1d
1.3%
1w
2.9%
1m
28.0%
3m
43.8%
6m
38.6%
1y
29.7%
5y
44.9%
10y
24.0%
all
27.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,881 1.3%
2,027
3,081
Company Overview

Sales
734 Cr
Growth: 10.9%
Profit after Tax
107 Cr
Growth: 4.3%
Small Cap
4,765 Cr
P/E: 39.8x
Industry P/E: 32.3x
Fundamentals

Sales (Cr) ₹ 734
Growth 10.9%
EBITDA 21.1%
P/S 6.5x
Dividend 0.8%
P/E 39.8x
Book Value ₹ 385
PEG Ratio 3.7x
ROE 17.7%
P/B 7.5x
Shareholding Pattern

Institutions
Promoters
Nucleus Life Trust (Mr. Harsh Vardhan Goenka Is A Trustee)
53.42 %
Ektara Enterprises Llp
15.2 %
Stel Holdings Limited
3.18 %
Harsh Vardhan Goenka
0.16 %
Mala Goenka
0.05 %
Others
Authum Investment And Infrastructure Limited
1.98 %
Iepf
0.86 %
Llp
0.02 %
Increase    Decrease    No change
Company Profile Detailed

RPG Life Sciences (RPGLS) is a pharmaceutical organization and was formerly known as Searle (India) Limited. It is a full spectrum world class, customer focussed, innovative pharmaceutical organisation. RPGLS started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to the RPG Group. The company’s name was changed to RPG Life Sciences Ltd effective April 1, 1999.
Investors (60)
Followers (5)